MGX Analyst Estimates: Price Targets, Revenue, Net Income, and EBIT Forecast - Metagenomi Inc - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 7.53 USD 11.72%

Updated:

Section:

Wall Street
Price Targets

Wall Street analysts forecast MGX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MGX is 22.95 USD with a low forecast of 21.21 USD and a high forecast of 26.25 USD.

MGX Lowest Forecast

Wall Street Target

MGX Average Forecast

Wall Street Target

MGX Highest Forecast

Wall Street Target

182% Upside

205% Upside

249% Upside

The latest public price target was made on Mar 28, 2024 by Maury Raycrof from Jefferies , who expects MGX stock to rise by 192% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst	Price Target	Date	Article
Maury Raycrof Jefferies	22 USD Upside 192%	1 month ago Mar 28, 2024	Metagenomi Inc (MGX) PT Lowered to $22 at Jefferies StreetInsider

Price Target	22 USD
Upside/Downside	192%

Pharming Group NV

106% Upside

Vertex Pharmaceuticals Inc

20% Upside

Shenzhen Kangtai Biological Products Co Ltd

85% Upside

AprilBio Co Ltd

82% Upside

Pharming Group NV

106% Upside

Vertex Pharmaceuticals Inc

20% Upside

Shenzhen Kangtai Biological Products Co Ltd

85% Upside

AprilBio Co Ltd

82% Upside

Krystal Biotech Inc

20% Upside

Century Therapeutics Inc

425% Upside

Biotest AG

19% Downside

Recursion Pharmaceuticals Inc

57% Upside

Revenue
Forecast

For the last 1 year the compound annual growth rate for Metagenomi Inc's revenue is 160%. The projected CAGR for the next 3 years is -13%.

160%

-13%

N/A

N/A

What are analyst estimates?

Operating Income
Forecast

N/A

N/A

N/A

N/A

What are analyst estimates?

Net Income
Forecast

N/A

N/A

N/A

N/A

What are analyst estimates?

See Also

Relative Valuation

Wall Street Estimates

Profitability Analysis

Solvency Analysis

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

According to Wall Street analysts, the average 1-year price target for MGX is 22.95 USD with a low forecast of 21.21 USD and a high forecast of 26.25 USD.

For the last 1 year the compound annual growth rate for Metagenomi Inc's revenue is 160%. The projected CAGR for the next 3 years is -13%.

Join more than 132,500+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.